The stock prices of both Caliper Life Sciences and Illumina increased more than 100 percent in 2010, while Vermillion and CombiMatrix led the decliners. Overall, the GWDN Index increased 16 percent, keeping pace with the broader market rebound.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.